Willard H. Dere

Willard H. Dere, M.D., joined the University of Utah Health Sciences Center in November 2014 as the Executive Director of Personalized Health and Professor of Internal Medicine. He currently serves roles as Associate Vice President for Research, co-director of the Utah Center for Clinical and Translational Science, and co-director of the Center for Genomic Medicine. Prior to rejoining academia, Dr. Dere was in the biopharmaceutical industry for 25 years, first at Eli Lilly, then at Amgen, where he was most recently Head of Global Development and Chief Medical Officer. Dr. Dere led the clinical development of raloxifene, rPTH 1-34, denosumab, and other drugs in a broad range of therapeutic areas. Dr. Dere received his undergraduate and medical degrees from the University of California, Davis. He was awarded the 2008 Transformational Leadership Award from UC Davis School of Medicine, multiple teaching awards from the University of Utah School of Medicine, and is a fellow in the American College of Physicians.